Hepatitis C
Hepatitis C virus (HCV) spreads through blood and causes chronic liver inflammation.
Early antiviral therapy can cure most cases and prevent complications.
Overview And Clinical Background
HCV infection often becomes chronic, leading to fibrosis or cirrhosis.
Recent antiviral drugs achieve cure rates above 95%.
- Transmission: Primarily through blood contact or transfusions.
- Can remain silent for years before symptoms appear.
- Risk factor: IV drug use and unsterilized medical tools.
Symptoms, Signs And Presentation
Early stages show fatigue and mild discomfort.
Jaundice and dark urine appear in advanced cases.
- Common symptom: Persistent tiredness and joint pain.
- Yellowing of skin and eyes in chronic infection.
- Red flag: Signs of liver failure or bleeding tendency.
Diagnosis Methods And Investigations
Serological and Molecular Tests
HCV antibody testing followed by RNA quantification confirms diagnosis.
Imaging evaluates liver damage.
- Anti-HCV test: Screens for prior exposure.
- HCV RNA: Confirms active viral replication.
- Liver biopsy or FibroScan assesses scarring.
Treatment Options And Surgical Techniques
Direct-acting antivirals (DAAs) revolutionized therapy, offering full viral clearance.
Supportive care maintains liver health.
- Conservative: Healthy diet and alcohol avoidance.
- Antiviral therapy: 12-week oral DAA regimen clears infection.
- Liver transplant for irreversible damage.
Recovery, Risks And Prognosis
Most patients recover fully with modern antivirals.
Chronic cases need regular liver monitoring.
Why Choose Us
CureU Healthcare provides personalized antiviral care with advanced diagnostics and experienced hepatologists.
Conclusion
Hepatitis C is now curable with early detection and precise treatment.
Timely care restores full liver function.
